Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Boric acid ear dressing for infected post-mastoidectomy temporal bone cavities
RBR-7m7yjdjPhase 3Recruiting
- Sponsor
- Faculdade de Medicina de Ribeirão Preto
- Start
- Jun 2023
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of boric acid, ciprofloxacin and dexamethasone in postprocedural disorder of ear and mastoid process and chronic suppurative otitis media (CSOM) (2 arms), sponsored by Faculdade de Medicina de Ribeirão Preto. Primary endpoint: Clinical response. Started Jun 2023; status: recruiting.
02
Drugs
boric acidciprofloxacindexamethasone
03
Conditions
postprocedural disorder of ear and mastoid processchronic suppurative otitis media (CSOM)
Beyond the preview
Go deeper on RBR-7m7yjdj.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on RBR-7m7yjdj.